Business

Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer

Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute CareDETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy. The custom

articleAmesite Inc.May 18, 20264/news/amesites-nursemagictm-wins-2700-census-home-care-enterprise-customer
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer

About this update from Amesite Inc.

Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care DETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy. The customer will deploy NurseMagic™ AI documentation across its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours1 per caregiver per week. This win represents a step-function increase in scale, substantially expanding NurseMagic™’s enterprise census footprint and demonstrating the platform’s ability to operate across complex organizations. Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “This 2,700-census deployment validates the strength of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients — without the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic™ is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding. This achievement reflects the successful transition from an assistive tool to core clinical infrastructure in the $1.5T+2-7 non-acute/post-acute market. For investors, it demonstrates that our platform scales into enterprise environments while preserving strong economics, even as we continue to maintain fiscal discipline.” “We executed this deployment with the same financial discipline we have applied across the company over the last several quarters,” said Sarah Berman, Principal Finance and Accounting Officer. “By building NurseMagic™ as an AI-first, configurable platform, we have been able to automate work that historically required significant human support. That approach has contributed to approximately 18% reduction in operating spend over the last 6 quarters, while supporting a growing base of paying customers. As we scale int...

View stock analysis, news, and events for Amesite Inc.

AmesiteAnn Marie Sastryenterprise censusAMSTdeploymentplatform scales